In the present study, we investigated whether TGFβ can modulate phosphorylation of the PTEN C-terminus in lung cancer cells and whether four-Ala substitution on the PTEN C- terminus (PTEN4A) could inhibit TGFβ-induced EMT and the related aberrant cell motility. Here, TGFB1 is linked to lung carcinoma.